1. Neuronal Signaling
  2. Monoamine Oxidase

Monoamine Oxidase

Monoamine oxidases (MAO) are a family of enzymes that catalyze the oxidation of monoamines. They are found bound to the outer membrane of mitochondria in most cell types in the body. They belong to the protein family of flavin-containing amine oxidoreductases. Monoamine oxidases catalyze the oxidative deamination of monoamines. Oxygen is used to remove an amine group from a molecule, resulting in the corresponding aldehyde and ammonia. Monoamine oxidases contain the covalently bound cofactor FAD and are, thus, classified as flavoproteins. Because of the vital role that MAOs play in the inactivation of neurotransmitters, MAO dysfunction is thought to be responsible for a number of psychiatric and neurological disorders. MAO-A inhibitors act as antidepressant and antianxiety agents, whereas MAO-B inhibitors are used alone or in combination to treat Alzheimer’sand Parkinson’s diseases.

Monoamine Oxidase Related Products (29):

Cat. No. Product Name Effect Purity
  • HY-B1496
    Tranylcypromine hemisulfate Inhibitor 99.82%
    Tranylcypromine hemisulfate, an LSD1 inhibitor, and also an irreversible, nonselective MAO inhibitor, is used in the treatment of depression.
  • HY-14197A
    Clorgiline hydrochloride Inhibitor 99.53%
    Clorgiline is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A) that is used in scientific research; structurally related to Pargyline.
  • HY-14199
    R-(-)-Deprenyl hydrochloride Inhibitor 99.86%
    R-(-)-Deprenyl Hydrochloride is a selective inhibitor of monoamine oxidase B (MAO-B).
  • HY-14605
    Rasagiline mesylate Inhibitor
    Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.
  • HY-70057
    Safinamide Inhibitor 99.55%
    Safinamide (EMD 1195686; FCE 26743) selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A.
  • HY-N0159
    Paeonol Inhibitor 99.98%
    Paeonol is an active extraction from the root of Paeonia suffruticosa, Paeonol inhibits MAO-A and MAO-B with IC50 of 54.6 μM and 42.5 μM, respectively.
  • HY-100975
    TB5 Inhibitor >98.0%
    TB5 is a potent, selective and reversible inhibitor of hMAO-B with a Ki value of 0.11±0.01 μM.
  • HY-N2336
    Rosmarinic acid racemate Inhibitor 98.01%
    Rosmarinic acid racemate is the racemate of Rosmarinic acid.
  • HY-A0091
    Pargyline hydrochloride Inhibitor 99.45%
    Pargyline hydrochloride is an irreversible inhibitor of monoamine oxidase (MAO) that is used clinically to treat moderate hypertension.
  • HY-B0886
    Iproniazid phosphate Inhibitor
    Iproniazid is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class.
  • HY-16677A
    Mofegiline hydrochloride Inhibitor
    Mofegiline Hcl (MDL72974A) is a potent and selective enzyme-activated irreversible inhibitor of MAO-B; shows marked selectivity for the B form (IC50 = 680 and 3.6 nM for MAO-A and MAO-B, respectively.
  • HY-N0529
    Rosmarinic acid Inhibitor 99.06%
    Rosmarinic acid (RA) is a widespread phenolic ester compound in the plants.
  • HY-B1018A
    Phenelzine sulfate Inhibitor >98.0%
    Phenelzine sulfate is a non-selective and irreversible monoamine oxidase inhibitor (MAOI), used as an antidepressant and anxiolytic.
  • HY-B0534
    Moclobemide Inhibitor
    Moclobemide(Ro111163) is a reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder.
  • HY-100027A
    Ro 41-1049 hydrochloride Inhibitor
    Ro 41-1049 hydrochloride is a selective, reversible, orally-active MAO-A inhibitor.
  • HY-14201
    Lazabemide Inhibitor
    Lazabemide(Ro 19-6327/000) is selective, reversible monoamine oxidase B (MAO-B) inhibitor (IC50 values are 0.03 and > 100 μM for MAO-B and MAO-A respectively).
  • HY-B1083
    Modaline sulfate Inhibitor 99.40%
    Modaline Sulfate is a MAO inhibitor, used in the treatment of depression.
  • HY-B0884
    Minaprine Inhibitor 99.82%
    Minaprine is a reversible inhibitor of MAO-A; weakly inhibit acetylcholinesterase; an antidepressant for treatment of depression.
  • HY-14200
    TVP1022 Inhibitor
    TVP1022 is the S-isomer of rasagiline, which is an anti-Parkinson drug, appears to have the same neuroprotective activity as the R-isomer, but is 1000-fold less active as an MAO-B inhibitor.
  • HY-B0938
    Mephentermine sulfate Inhibitor
    Mephentermine sulfate is a cardiac stimulant, before as a stimulant in psychiatry, has been used as a treatment for low blood pressure.